PureTech Health
Overview
PureTech Health is a clinical-stage biotherapeutics company with a hub-and-spoke model that involves discovering, developing, and commercializing medicines by creating and funding new companies, known as 'Founded Entities', around promising assets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Seaport Therapeutics | Oct 2024 | Series B | - |
| Celea Therapeutics | Jul 2026 | Seed | Co-investor |
| Sonde Health | Dec 2022 | Series B | Co-investor |
| Follica, Inc. | Aug 2008 | Series B | Co-investor |
| Vedanta Biosciences | Apr 2023 | VC Round | Co-investor |
Key People
Kana Nakajima DeLuca
Director Of Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is PureTech Health based?
PureTech Health is headquartered in Boston, Massachusetts, United States.
When was PureTech Health founded?
PureTech Health was founded in 2005.
How many portfolio companies does PureTech Health have?
PureTech Health has 5 portfolio companies in Caplight's dataset.
What are some companies in PureTech Health's portfolio?
Portfolio companies visible on Caplight include Seaport Therapeutics, Celea Therapeutics, Sonde Health, Follica, Inc., Vedanta Biosciences.
What was PureTech Health's most recent investment shown here?
PureTech Health's most recent investment in this portfolio sample was in Celea Therapeutics in 2026.
What sectors does PureTech Health focus on?
PureTech Health focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does PureTech Health focus on?
PureTech Health typically invests at the MultiStage stage.
What is PureTech Health's AUM?
PureTech Health's assets under management are estimated between $250.0M and $500.0M.